Signals 

/

Funding Signal

Funding Signal

Solius Labs Secures $23M in Latest Funding Round

June 21, 2026

Healthcare & Biotech

Series A

$23M

Series A

Key Facts

Company

Solius Labs

Amount Raised

$23,000,000

Round

Series A

Sector

Hospitals and Health Care

What Happened

Solius Labs, a company focused on healthcare solutions, announced on June 21, 2026, that it has successfully raised $23 million in a Series A funding round. This significant capital injection is expected to fuel the company's growth and product development initiatives. The Solius Labs news indicates a strong investor confidence in their market approach.

While specific lead investors were not disclosed, this funding positions Solius Labs to further innovate within its sector. The company's financial health is a key indicator for those tracking Solius Labs competitors and considering Solius Labs pricing or Solius Labs reviews.

Who Is Solius Labs

Founded in 2011, Solius Labs is a US-based technology company operating within the Hospitals and Health Care industry. The company is dedicated to enhancing health outcomes through innovative solutions.

Solius Labs specializes in providing a healthcare workforce management platform designed to optimize operations for healthcare providers. Their offerings aim to address critical challenges faced by hospitals and health systems today.

What Does Solius Labs Do

Solius Labs develops a comprehensive healthcare workforce management platform that helps hospitals and health systems streamline their staffing processes. This platform is crucial for improving efficiency and reducing operational costs.

Their technology includes advanced hospital staffing analytics, enabling administrators to make data-driven decisions. The platform also features nurse scheduling optimization tools, which are vital for managing complex shift patterns and ensuring adequate coverage.

A core component of their offering is a sophisticated float pool algorithm, which intelligently deploys staff across different units based on real-time needs. This capability, alongside their nurse demand forecasting SaaS, contributes significantly to clinical labor cost reduction and acts as a travel nurse replacement tech, offering substantial savings for health systems seeking health system labor margin improvement.

Healthcare & Biotech Market Context

The healthcare & biotech sector continues to attract substantial investment, as evidenced by the latest healthcare & biotech funding rounds. Companies like Solius Labs are benefiting from a robust environment for healthcare & biotech venture capital.

Analysts are closely watching healthcare & biotech startups to watch 2026, with many anticipating significant healthcare & biotech M&A 2026 activity. The ongoing demand for innovative solutions in patient care and operational efficiency drives much of this investment, as reflected in recent healthcare & biotech funding news 2026.

The market is characterized by a push for digital transformation, with a strong emphasis on technologies that can improve patient outcomes and reduce costs. This trend creates fertile ground for companies offering specialized platforms like Solius Labs.

Why This Matters

This funding round is a significant development for Solius Labs, reinforcing its position in the competitive healthcare technology landscape. The capital infusion will allow them to accelerate product development and market reach.

The investment also signals growing confidence in solutions that address critical healthcare staffing challenges. This puts Solius Labs in closer competition with QGenda in the workforce management market, as both aim to optimize hospital operations.

For B2B vendors, this funding represents a clear opportunity to engage with Solius Labs. The company will likely be investing in new technologies, partnerships, and talent to scale its operations, creating potential sales opportunities for enterprise software, consulting, and recruitment services.

What to Watch

In the next 6-12 months, we can expect Solius Labs to focus on expanding its product features, particularly in areas like advanced predictive analytics for staffing. Increased hiring, especially in engineering and sales, is also probable as they aim to capture a larger market share.

The company may also explore strategic partnerships to integrate its platform with other healthcare IT systems. Keep an eye on their announcements for new client acquisitions and potential geographic expansion as they leverage this new capital.

Get signals like this sent to your CRM

We monitor the internet for events. Given your business, we convert them into signals, piped straight into your CRM linked to relevant accounts and contacts, ready to use - no manual research.

Book a 15 min call
Dominykas Rukas - Revenanas